Y Mabs Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Y Mabs Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Y Mabs Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Y Mabs Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $418k | 26k | 16.24 |
| 2023-12-31 | $344k | 50k | 6.82 |
| 2023-09-30 | $34k | 6.3k | 5.40 |
| 2023-06-30 | $49k | 7.3k | 6.70 |
| 2023-03-31 | $237k | 47k | 5.00 |
| 2022-12-31 | $48k | 9.9k | 4.87 |
| 2022-09-30 | $929k | 64k | 14.42 |
| 2022-06-30 | $43k | 2.8k | 15.20 |
| 2022-03-31 | $68k | 5.8k | 11.73 |
| 2021-12-31 | $973k | 60k | 16.22 |
| 2021-09-30 | $498k | 18k | 28.50 |
| 2021-06-30 | $232k | 6.9k | 33.89 |
| 2021-03-31 | $1.0M | 34k | 30.22 |
| 2020-12-31 | $602k | 12k | 49.55 |
| 2020-09-30 | $1.9M | 49k | 38.41 |
| 2020-06-30 | $2.2M | 52k | 43.20 |
| 2020-03-31 | $281k | 11k | 26.04 |
| 2019-12-31 | $878k | 28k | 31.28 |
| 2019-09-30 | $331k | 13k | 26.06 |
| 2019-06-30 | $300k | 13k | 22.87 |
| 2019-03-31 | $426k | 16k | 26.21 |
| 2018-12-31 | $210k | 10k | 20.31 |